Research Progress of Liujunzi Decoction in the Treatment of Tumor-Associated Anorexia

Xipei Wu,Yongzhao Dai,Ke Nie

DOI: https://doi.org/10.2147/DDDT.S365292

2022-06-07

Abstract:Xipei Wu, Yongzhao Dai, Ke Nie School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China Correspondence: Ke Nie, School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, People's Republic of China, Email ; Tumor-associated anorexia, mainly including cancerous anorexia and chemotherapy-induced anorexia, severely reduces the life quality of cancer patients but lacks of effective control until now. Liujunzi decoction (LJZD), a classical tonifying formula in traditional Chinese medicine, has promising effect in preventing and treating many kinds of anorexia. A growing number of evidence showed that LJZD is able to improve tumor-associated anorexia. Up to March 2022, a total of 58 articles studying LJZD or Rikkunshito (the name of LJZD in Japanese herbal medicine) in the treatment of tumor-associated anorexia are searched out in PubMed. This paper summarizes the effect of LJZD in ameliorating tumor-associated anorexia, in order to provide a theoretical basis for the clinical application of LJZD in treating tumor-associated anorexia, laying foundation for further research. Keywords: Liujunzi decoction, tumor-associated anorexia, review Cancer is one of the major public health problems around the world, according to the latest data from the International Agency for Research on Cancer, 19.3 million new cancer cases were diagnosed globally and nearly 10 million deaths occurred in 2020. 1 Although there are new cancer treatments such as biological therapy and targeted therapy, chemotherapy is one of the most effective and commonly used treatments. However, anorexia is one of the most common complications of advanced cancer patients and one of the most common side effects of antineoplastic agents, which will lead to adverse consequences such as reduced food intake, decreased body weight and affect the therapeutic effect of cancer. 2–6 Therefore, tumor-associated anorexia mainly includes cancerous anorexia (CA) caused by cancer itself, and chemotherapy-induced anorexia (CIA) caused by chemotherapeutic drugs. 7–10 At present, appetite stimulation, drug intervention and nutritional therapy are often used in the clinical treatment of tumor-associated anorexia, but the effect is unsatisfactory. 11,12 For example, progesterone such as megestrol acetate is often used in clinical practice to prevent and treat tumor cachexia. In addition to its efficacy in inhibiting tumor, this drug also has the efficacy of promoting appetite and improving anorexia, but it can lead to side effects such as venous thrombosis, sodium water retention, uterine bleeding, electrolyte disorder, and renal insufficiency. 13–15 Studies have shown that anamorelin and thalidomide have positive effects in the treatment of CA, but the mechanisms are not so clear and the high cost deters patients. 16,17 In view of the lack of effective drugs for CIA in clinical practice, it is urgent to develop safe and effective drugs for tumor-associated anorexia. 18 Liujunzi decoction (LJZD), a classical tonifying prescription in traditional Chinese medicine (TCM), originates from the Yi Xue Zheng Zhuan compiled in the Ming Dynasty. It has the effect of benefiting vital energy and tonifying spleen, removing dampness to reduce phlegm, and mainly treats phlegm-dampness due to deficiency of the spleen syndrome. In 2008, an epoch-making study by Japanese scholars found that Rikkunshito could improve appetite in a cisplatin-induced anorexia model in rats by promoting the secretion of ghrelin, which immediately attracted the attention and research of a large number of scholars. 19,20 Clinical study found that LJZD and modified LJZD improved tumor-associated anorexia effectively. 18,21–33 A number of animal experiments have also proved that this prescription has the efficacy of preventing and treating tumor-associated anorexia. 19,34–41 In view of the exact effect of LJZD in improving tumor-associated anorexia, this paper summarizes the literature of LJZD in the treatment of tumor-associated anorexia from CA and CIA, in order to provide ideas for further application of LJZD. CA is anorexia caused by advanced tumor. In advanced tumor often caused a complex systemic disease "cachexia", leading to anorexia, weakness, muscle loss and anemia clinical features, cause to further reduce the quality of life. 7 CA does not have a specific name in traditional Chinese medical science (TCMS). According to symptoms, it can be classified into the categories of "fullness", "asthenia and fatigue", "anorexia" or "insufficient food" in TCMS. 42 Its etiology is mostly due to weakness of spleen and stomach, indigestion of diet, and emotional disorders, resulting in adverse middle energizer -Abstract Truncated-